Trending archive
Every article that has appeared in Trending stays here. Search by title, journal, author or PMID, and narrow by date.
1845 articles
July 202624
False-positive HIV-1 RNA detection after CAR-T cell therapy in a multiple myeloma patient: multi-assay comparison confirms dual-target cross-reactivity.
A patient with multiple myeloma undergoing CAR-T cell therapy tested positive for HIV-1 RNA using two dual-target assays, showing low copy numbers.
Relationship between miRNAs dysregulation and the metastatic process associated with epithelial-mesenchymal transition in oral squamous cell carcinoma: A systematic review.
This systematic review evaluated the link between miRNA dysregulation and the metastatic process related to epithelial-mesenchymal transition (EMT) in oral squamous cell carcinoma (OSCC).
Outcomes at rapid diagnostic centres and the association between non-specific symptoms and cancer: A systematic review and meta-analyses of up to 21,392 patients.
This systematic review and meta-analysis evaluated the association between non-specific symptoms (NSSs) and cancer in up to 21,392 patients diagnosed through rapid diagnostic centres.
Immune checkpoint inhibitor-induced type 1 diabetes mellitus: incidence, risk factors, and prognostic implications - a systematic review and meta-analysis.
This systematic review and meta-analysis examined the incidence and risk factors of immune checkpoint inhibitor-induced type 1 diabetes mellitus (ICI-T1DM) in adult cancer patients.
HER2-positive rectal adenocarcinoma metastatic to the pancreas complicated by obstructive pancreatitis and an infected pseudocyst: a case report.
A man in his 60s presented with cerebellar masses; PET-CT also showed hypermetabolic lesions in the rectum and pancreas. Testing identified HER2-positive, RAS/BRAF wild-type rectal adenocarcinoma.
532-nm KTP Laser Treatment of Epidermal Growth Factor Receptor Inhibitor-Associated Paronychia: A Case Report.
A 67-year-old man with metastatic non-small cell lung cancer developed painful inflammation around multiple fingernails and both great toenails while receiving amivantamab.
An unanchored matching-adjusted indirect comparison of the efficacy of zanubrutinib versus ibrutinib for the treatment of relapsed/refractory mantle-cell lymphoma.
This study conducted an unanchored matching-adjusted indirect comparison to evaluate the efficacy of zanubrutinib versus ibrutinib in patients with relapsed/refractory mantle-cell lymphoma (R/R MCL).
Efficacy of doxorubicin-loaded graphene nanoplatform chemo-photothermal therapy versus photothermal therapy alone for breast cancer xenograft tumors: a meta-analysis.
This meta-analysis evaluated the efficacy of doxorubicin-loaded graphene nanoplatform chemo-photothermal therapy (CPT) versus photothermal therapy (PTT) alone in breast cancer xenograft models.
Applying Spiritual AIM With Pediatric Cancer Patients and Families: A Composite Case Report.
This case report discusses a five-year-old pediatric cancer patient, Manuel, and his father, Luis, highlighting their experiences with spiritual care.
Network meta-analysis of immune checkpoint inhibitors in BCG-naïve, high-risk non-muscle-invasive bladder cancer.
This network meta-analysis evaluated the efficacy of immune checkpoint inhibitors (ICIs) combined with BCG in BCG-naïve high-risk non-muscle-invasive bladder cancer (NMIBC).
Nurse-led attribution remodeling training based on the Neuman systems model to enhance resilience, adaptive coping, and attributional style in women newly diagnosed with breast cancer: A randomized controlled trial.
This randomized controlled trial evaluated a nurse-led attribution remodeling training intervention for 130 women newly diagnosed with breast cancer.
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.
The TRIANGLE trial evaluated the impact of rituximab maintenance (RM) on progression-free survival (PFS) and overall survival (OS) in younger, untreated patients with mantle cell lymphoma (MCL) receiving…
Therapeutic drug monitoring guides personalized ponatinib dose reduction for chronic myeloid leukemia.
A 66-year-old woman with chronic-phase chronic myeloid leukemia was switched to ponatinib due to nilotinib-induced thrombocytopenia.
Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY-1 and MOMENTUM Trials.
These post hoc analyses of two phase 3 randomised trials examined how quickly patients with myelofibrosis and baseline hemoglobin < 10 g/dL achieved hemoglobin ≥ 10 g/dL with momelotinib, and whether this was associated…
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up.
This nationwide Icelandic population-based screening study, which included a randomized trial of follow-up strategies, assessed clinical and psychological outcomes after monoclonal gammopathy screening.
Adenocarcinoma with enteroblastic differentiation with choriocarcinoma components arising in long-segment Barrett's esophagus: a report of autopsy case.
An 87-year-old man was admitted with anorexia. Endoscopy showed a nearly circumferential elevated lesion at the lower esophagus and esophagogastric junction; biopsy identified adenocarcinoma with enteroblastic…
Clinical outcomes of Epstein-Barr virus infection/reactivation following CAR-T cell therapy: A systematic review.
This systematic review evaluated the occurrence and outcomes of Epstein-Barr virus (EBV) infection or reactivation in adults undergoing CAR-T therapy.
Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.
The phase III ENHANCE study evaluated the efficacy and safety of magrolimab plus azacitidine versus placebo plus azacitidine in treatment-naïve patients with higher-risk myelodysplastic syndromes.
Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.
This randomized phase 2 trial evaluated CPX-351 versus CLAG-M in 60 medically unfit adults with untreated acute myeloid leukemia (AML).
Is Level IIB Dissection Necessary in the Clinically N0 Neck? A Systematic Review and Meta-Analysis in Head and Neck Squamous Cell Carcinoma.
This systematic review and meta-analysis evaluated the necessity of level IIB dissection in clinically node-negative (cN0) head and neck squamous cell carcinoma (HNSCC).
Machine Learning for Predicting Ki-67 Expression in Renal Tumors: A Systematic Review And Meta-Analysis.
This systematic review and meta-analysis evaluated the diagnostic performance of machine learning models in predicting Ki-67 expression in renal tumors, analyzing data from seven retrospective cohort studies involving…
Heterogeneity and Evolution of 68 Ga-Pentixafor PET/CT Signals in Extramedullary Multiple Myeloma.
A 55-year-old man with multiple myeloma presented for 68 Ga-pentixafor PET/CT, revealing an extramedullary soft-tissue lesion misidentified as a mesenchymal tumor due to low tracer uptake.
Rechallenge With 177 Lu-PSMA Radioligand Therapy in Metastatic Castration-resistant and Hormone-sensitive Prostate Cancer : Lessons From a Multicase Experience.
Four patients with metastatic hormone-sensitive and castration-resistant prostate cancer were treated with 177 Lu-PSMA-617 radioligand therapy.
Laparoscopic extended cholecystectomy with extended left hemi-hepatectomy (left lobe & S5), after interventional therapy and neoadjuvant chemotherapy for stage IIIb GBC.
The benefits of the use of interventional therapy and neoadjuvant chemotherapy [1] to improve post-operative outcomes and potentially reduce the rate of recurrence during a laparoscopic extended cholecystectomy with…
Stay updated for free
Get the 3 most interesting publications in one specialty each week.
Weekly email. Unsubscribe anytime.
Want this personalized?
Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.
- Your specialties
- Your filters and thresholds
- Clinical Research + Case Reports, tuned separately
- Automatic weekly delivery
- Audio and text
Prefer listening? Personalized audio digests are available with Pro.